Asset Details
Do you wish to reserve the book?
Methicillin-Resistant Staphylococcus aureus: An Evolving Pathogen
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Methicillin-Resistant Staphylococcus aureus: An Evolving Pathogen
Do you wish to request the book?
Methicillin-Resistant Staphylococcus aureus: An Evolving Pathogen
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Methicillin-Resistant Staphylococcus aureus: An Evolving Pathogen
2014
Overview
The horizontal transmission of methicillin resistance to Staphylococcus aureus (MRSA) in hospital and community settings, and growing prevalence of these strains, presents a significant clinical challenge to the management of serious infections worldwide. While infection control initiatives have stemmed the rising prevalence, MRSA remains a significant pathogen. More recently, evidence that MRSA is becoming resistant to glycopeptides and newer therapies raises concern about the use of these therapies in clinical practice. Vancomycin resistance has become evident in select clinical settings through rising MICs, growing awareness of heteroresistance, and emergence of intermediate-resistant and fully resistant strains. While resistance to linezolid and daptomycin remains low overall, point mutations leading to resistance have been described for linezolid, and horizontal transmission of cfr-mediated resistance to linezolid has been reported in clinical isolates. These resistance trends for newer therapies highlight the ongoing need for new and more potent antimicrobial therapies.
Publisher
OXFORD UNIVERSITY PRESS,Oxford University Press
Subject
Anti-Bacterial Agents - pharmacology
/ Bacteria
/ Glycopeptides - pharmacology
/ Humans
/ Methicillin resistant staphylococcus aureus
/ Methicillin-Resistant Staphylococcus aureus - drug effects
/ Methicillin-Resistant Staphylococcus aureus - genetics
/ Methicillin-Resistant Staphylococcus aureus - physiology
/ Plasmids
/ Staphylococcal Infections - epidemiology
